ARCHIVES

FDA Ceases Exclusion Of Women From Early Drug Studies

This article is from The Cancer Letter archive.

Vol. 19 No. 19 | May 7, 1993

Download PDF Visit The Full Archive

Related Articles

Two Groups Take Different Approaches To Toxicity Of Saltz Regimen In Studies

June 29, 2001

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003

In Brief: Cancer Claims Morris Kupchan, Who Found Promising New Antitumor Drugs In Plants

October 29, 1976

Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer

November 26, 2010

“Tone” Of Statement Lacks Balance, Klausner Says

January 31, 1997

Freeman Reappointed President’s Cancer Panel Chairman

September 16, 1994